The Locum Consultancy awarded Tier 2
Written by Mark Kelly
Priding itself on supplying the very highest calibre medical staffing to hospitals nationwide and its growing reputation for supplying last minute requirements in the most difficult to fill positions, The Locum Consultancy (TLC) is delighted to confirm its position as a Tier 2 supplier for Medical and General Practitioner Locums to Pennine Acute Hospitals NHS Trust, procured through the HealthTrust Europe (HTE) Medical Locums Framework Agreement.
Pennine Acute Hospitals NHS Trust is the largest non-teaching Trust in the UK and employs over 8,000 staff across four sites in Greater Manchester; North Manchester General, Fairfield General Hospital, The Royal Oldham Hospital and Rochdale Infirmary.
As one of the fastest growing medical staffing suppliers in the UK, TLC is very proud of its appointment as a Tier 2 supplier. Director David Newton commented: “The continued professional development of our staff, the ability to fully understand and satisfy the requirements of our clients and the innovative recruitment provision that our team is able to offer has seen TLC become an integral part of several Trusts’ medical staffing solutions.”
The Locum Consultancy (TLC), founded in 2008, is one of the fastest growing medical recruitment agencies in the UK and has since been successful in gaining a place on every major national framework agreement, supplying locum doctors to NHS bodies including the Government Procurement Service, Health Trust Europe and London Procurement Partnership frameworks.
As a specialist volume provider with full UK NHS coverage, TLC is committed to supporting Trusts through its locums that embrace the right values and behaviours as defined in the NHS Constitution; Care, Compassion, Competence, Communication, Courage and Commitment.
Through a continuous focus in the pursuit of excellence, TLC has been awarded the 2013 Gold Audit Status for HTE & LPP and has built an enviable reputation for its provision of superior quality doctors, speed of response, professionalism and first-rate client and candidate care.
About the Author
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”